Recent advances in gene therapy for bone tissue engineering
Journal of Tissue Engineering and Regenerative Medicine · 2022-12 · 16 (12) · 1121-1137
DOI: 10.1002/term.3363 ↗At a glance
Übersichtsarbeit in Journal of Tissue Engineering and Regenerative Medicine, published online on 2022-11-16. Written by Fatemeh Ranjbarnejad and 4 co-authors. Institution: Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. Major MEDLINE topics: Tissue Engineering, Genetic Therapy. Cited 21 times so far (Crossref); 131 references. Funded by: Kermanshah University of Medical Sciences.
Abstract (original language)
Autografting, a major treatment for bone fractures, has potential risks related to the required surgery and disease transmission. Bone morphogenetic proteins (BMPs) are the most common osteogenic factors used for bone-healing applications. However, BMP delivery can have shortcomings such as a short half-life and the high cost of manufacturing the recombinant proteins. Gene delivery methods have demonstrated promising alternative strategies for producing BMPs or other osteogenic factors using engineered cells. These approaches can also enable temporal overexpression and local production of the therapeutic genes in the target tissues. This review addresses recent progress on engineered viral, non-viral, and RNA-mediated gene delivery systems that are being used for bone repair and regeneration. Advances in clustered regularly interspaced short palindromic repeats/Cas9 genome engineering for bone tissue regeneration also is discussed.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Department of Tissue Engineering, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Tools for Bio-Imaging, Max-Planck-Institute for Biological Intelligence, Martinsried, Germany.
- Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
ORCID profiles: Leila Rezakhani
Funding
- Kermanshah University of Medical Sciences
Cite
APA
Ranjbarnejad, F., Khazaei, M., Shahryari, A., Khazaei, F., & Rezakhani, L. (2022). Recent advances in gene therapy for bone tissue engineering. Journal of Tissue Engineering and Regenerative Medicine, 16(12), 1121-1137. https://doi.org/10.1002/term.3363
Vancouver
Ranjbarnejad F, Khazaei M, Shahryari A, Khazaei F, Rezakhani L. Recent advances in gene therapy for bone tissue engineering. Journal of Tissue Engineering and Regenerative Medicine. 2022;16(12):1121-1137. doi:10.1002/term.3363
BibTeX
@article{Ranjbarnejad2022,
author = {Ranjbarnejad, Fatemeh and Khazaei, Mozafar and Shahryari, Alireza and Khazaei, Fatemeh and Rezakhani, Leila},
title = {Recent advances in gene therapy for bone tissue engineering},
journal = {Journal of Tissue Engineering and Regenerative Medicine},
year = {2022},
volume = {16},
number = {12},
pages = {1121--1137},
doi = {10.1002/term.3363}
}
EUVIMED